INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,789,515 | +13.2% | 130,342 | +37.5% | 0.08% | -1.2% |
| Q2 2023 | $6,000,267 | +29.2% | 94,761 | +10.5% | 0.08% | +25.0% |
| Q1 2023 | $4,642,767 | +15.7% | 85,739 | +13.1% | 0.06% | +1.6% |
| Q4 2022 | $4,013,506 | +24.2% | 75,841 | -45.3% | 0.06% | +70.3% |
| Q3 2022 | $3,230,227 | -45.6% | 138,712 | +33.3% | 0.04% | -68.4% |
| Q2 2022 | $5,938,000 | -45.1% | 104,036 | -41.2% | 0.12% | -10.0% |
| Q1 2022 | $10,818,000 | -15.2% | 176,801 | -27.4% | 0.13% | +42.9% |
| Q4 2021 | $12,751,000 | +99.5% | 243,600 | +42.1% | 0.09% | +65.5% |
| Q3 2021 | $6,391,000 | +78.3% | 171,440 | +95.2% | 0.06% | +66.7% |
| Q2 2021 | $3,585,000 | +56.6% | 87,817 | +30.2% | 0.03% | +26.9% |
| Q1 2021 | $2,289,000 | +6.7% | 67,457 | 0.0% | 0.03% | +36.8% |
| Q4 2020 | $2,145,000 | -90.4% | 67,457 | -89.6% | 0.02% | -95.3% |
| Q4 2019 | $22,277,000 | +2425.7% | 649,300 | +449.8% | 0.40% | +1587.5% |
| Q3 2019 | $882,000 | +94.3% | 118,091 | +237.4% | 0.02% | +84.6% |
| Q2 2019 | $454,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |